How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) EPS for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million.

What other stocks do shareholders of BG Medicine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BG Medicine investors own include Aeterna Zentaris (AEZS) , Glu Mobile (GLUU) , Blue Ridge Mountain Resources (MHRCQ) , ARCA biopharma (ABIO) , Athersys (ATHX) , Catalyst Pharmaceuticals (CPRX) , InterCloud Systems (ICLD) , Inovio Pharmaceuticals (INO) , LightPath Technologies (LPTH) .

How do I buy shares of BG Medicine?

Shares of BGMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BGMD

BG Medicine (BGMD) Stock Price, News & Analysis

→ Nvidia Has a BIG Problem — Here’s Who Benefits MOST (From Weiss Ratings) (Ad)

Free BGMD Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 24 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Short Interest

Get BG Medicine alerts:

Ad Weiss Ratings

Nvidia Has a BIG Problem — Here’s Who Benefits MOST

#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'

If You Missed Out On The AI Boom, Take These 3 Steps

About BG Medicine Stock (OTCMKTS:BGMD)

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Ad Weiss Ratings

Nvidia Has a BIG Problem — Here’s Who Benefits MOST

If You Missed Out On The AI Boom, Take These 3 Steps

BGMD Stock News Headlines

April 6, 2024 | forbes.com

Modernizing Medicine

February 28, 2024 | benzinga.com

BG Medicine Stock (OTC:BGMD), Insider Trading Activity

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

July 22, 2023 | bbc.co.uk

Medicine Through Time

June 7, 2023 | finance.yahoo.com

BGMD - BG Medicine, Inc.

April 22, 2023 | forbes.com

Jiangsu Hengrui Medicine

February 15, 2023 | thestreet.com

Why BG Medicine (BGMD) Stock Is Plunging Today

December 31, 2022 | thestreet.com

Why BG Medicine (BGMD) Is Up Today

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

September 3, 2022 | seekingalpha.com

BGMD BG Medicine, Inc.

August 15, 2021 | nasdaq.com

BG Medicine Inc (BGMD)

August 11, 2021 | barrons.com

BG Medicine Inc.

See More Headlines

Receive BGMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BG Medicine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/17/2015
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostic substances
Sub-Industry: Life Sciences Tools & Services
Current Symbol: OTCMKTS:BGMD
Previous Symbol: NASDAQ:BGMD
CUSIP: 08861T10
CIK: 1407038
Web: www.bg-medicine.com
Phone: (508) 549-5710
Fax: 781-895-1119
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Dr. Paul R. Sohmer (Age 75)
CEO, President & Director
Comp: $429.17k
Mr. Stephen P. Hall (Age 73)
CFO, Executive VP & Treasurer
Comp: $351.03k
Dr. Aram Adourian Ph.D. (Age 54)
Chief Scientific Officer
Comp: $275k

Key Competitors

View All Competitors

BGMD Stock Analysis - Frequently Asked Questions

How were BG Medicine's earnings last quarter?: BG Medicine, Inc. (OTCMKTS:BGMD) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) EPS for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million.
What other stocks do shareholders of BG Medicine own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BG Medicine investors own include Aeterna Zentaris (AEZS), Glu Mobile (GLUU), Blue Ridge Mountain Resources (MHRCQ), ARCA biopharma (ABIO), Athersys (ATHX), Catalyst Pharmaceuticals (CPRX), InterCloud Systems (ICLD), Inovio Pharmaceuticals (INO), LightPath Technologies (LPTH).
How do I buy shares of BG Medicine?: Shares of BGMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BGMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial